Dividend stocks today: Shares of six companies, namely Sun Pharmaceutical Industries, Container Corporation of India, IRB Infrastructure Developers, Triveni Turbine, Sharda Cropchem and India ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.40% to 1,749.50 Indian rupees Friday, on what proved to be an all-around dismal trading session for the stock market, with the BSE ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.77% to 1,753.40 Indian rupees Wednesday, on what proved to be an all-around poor trading session for the stock market, with the BSE ...

BENGALURU (Reuters) -India's drug regulator has found more than 50 drugs, including some batches of widely used antacids and paracetamol, to be substandard or fake, according to government documents.

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

Sun Pharmaceutical Industries or Sun Pharma is India’s leading pharmaceutical firm which is known for the production of Active Pharmaceutical Ingredients (APIs). The company is headquartered in ...

Delhi-NCR experienced light rainfall on Tuesday morning, offering a temporary relief from pollution, although air quality remains in the 'poor' category. The rain, influenced by a Western ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

These puzzles usually consist of two almost identical images placed side by side, with the goal being to find the differences between them. The differences can vary, such as changes in colour or ...

Below, you’ll find a list of Baltimore Sun editorial staff, their email addresses and phone numbers. To give The Sun newsroom a general tip, email newstips@baltimoresun.com or call 410-332-6100.

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.